Sale!

Immunohistochemistry NKX3.1 Test

Original price was: $112.Current price is: $88.

-21%

The Immunohistochemistry NKX3.1 Test is a specialized diagnostic procedure that detects the NKX3.1 protein marker in tissue samples, primarily used for identifying prostate cancer and distinguishing it from other malignancies. This advanced immunohistochemical analysis provides crucial information for accurate cancer diagnosis and treatment planning. The test is particularly valuable for confirming prostate origin in metastatic cancers and evaluating prostate tissue in challenging diagnostic cases. Available for just $88 USD, this test offers reliable results with a turnaround time of 3-5 days. Our comprehensive testing service helps physicians make informed decisions about patient care and treatment strategies.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Immunohistochemistry NKX3.1 Test: Advanced Prostate Cancer Marker Detection

Understanding the Immunohistochemistry NKX3.1 Test

The Immunohistochemistry NKX3.1 Test represents a cutting-edge diagnostic approach in cancer pathology, specifically designed to detect the presence of the NKX3.1 protein marker in tissue samples. This highly specific test plays a crucial role in modern oncology by providing definitive identification of prostate tissue origin in various clinical scenarios. As a nuclear transcription factor expressed almost exclusively in prostate epithelium, NKX3.1 serves as an invaluable biomarker for distinguishing prostate cancer from other malignancies.

What Does the NKX3.1 Test Measure?

This specialized immunohistochemistry test specifically detects the NKX3.1 protein, which is:

  • A prostate-specific homeobox gene product
  • Expressed in both benign and malignant prostate tissue
  • Highly specific for prostate epithelial cells
  • Maintained in most prostate cancer cases, including high-grade tumors

Clinical Applications and Who Should Consider This Test

Primary Clinical Indications

The Immunohistochemistry NKX3.1 Test is particularly valuable for patients presenting with:

  • Metastatic cancer of unknown primary origin
  • Suspected prostate cancer metastases to distant sites
  • Challenging prostate biopsy interpretations
  • Differentiation of prostate cancer from other malignancies
  • Evaluation of poorly differentiated tumors

Symptoms and Clinical Scenarios

Patients who may benefit from this testing include those with:

  • Elevated PSA levels with ambiguous biopsy results
  • Metastatic disease where prostate origin is suspected
  • Previous inconclusive prostate cancer diagnoses
  • Need for precise tissue origin confirmation in cancer staging

Key Benefits of NKX3.1 Immunohistochemistry Testing

Enhanced Diagnostic Accuracy

The NKX3.1 test provides superior specificity compared to traditional prostate markers, offering:

  • Higher specificity than PSA for prostate tissue identification
  • Reliable detection in both primary and metastatic prostate cancers
  • Excellent performance in high-grade and treatment-resistant tumors
  • Minimal cross-reactivity with non-prostate tissues

Clinical Decision Support

This test empowers healthcare providers with:

  • Definitive confirmation of prostate cancer diagnosis
  • Accurate identification of metastatic prostate cancer
  • Guidance for appropriate treatment selection
  • Improved patient stratification and prognosis assessment

Understanding Your Test Results

Interpretation Guidelines

Your NKX3.1 test results will be interpreted as follows:

  • Positive Result: Nuclear staining indicates prostate origin, supporting prostate cancer diagnosis
  • Negative Result: Absence of staining suggests non-prostate origin of the tumor
  • Focal Staining: Limited positive areas may require correlation with clinical findings
  • Intensity Grading: Staining intensity provides additional diagnostic information

Clinical Correlation

It’s important to understand that:

  • Results should be interpreted in clinical context
  • Correlation with other markers may be necessary
  • Your physician will discuss implications for your treatment plan
  • False positives are extremely rare due to high specificity

Test Pricing and Availability

Test Name Discount Price Regular Price
Immunohistochemistry NKX3.1 Test $88 USD $112 USD

Turnaround Time and Sample Requirements

Our testing service offers efficient processing with:

  • Sample Acceptance: Daily by 6 PM
  • Report Time: 3 days for tissue blocks, 5 days for small specimens
  • Sample Type: Formalin fixed paraffin embedded tissue block or tissue in formalin
  • Shipping: Room temperature with complete clinical history

Nationwide Testing Availability

We proudly serve patients across the United States with testing facilities in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.

Book Your Immunohistochemistry NKX3.1 Test Today

Take the next step in your cancer diagnosis journey with our specialized NKX3.1 testing service. Our experienced oncology team is ready to provide you with accurate, reliable results that can make a significant difference in your treatment planning.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your test or speak with our genetic counseling specialists. We’re here to answer your questions and help you understand how this advanced testing can benefit your specific situation.

Don’t let diagnostic uncertainty delay your treatment decisions. With our affordable pricing at just $88 USD and rapid turnaround times, you can get the answers you need quickly and confidently. Trust General Genetics Corporation for your specialized cancer marker testing needs.